Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
Adding point-of-care (POC) susceptibility testing to POC culture does not improve appropriateness of antibiotic prescribing for patients with suspected…
From - Diagnostic Testing & Emerging Technologies
A new study validates the long-held assumption that intensity of care is consistently higher at teaching hospitals, compared to nonteaching hospitals. Patients in Texas admitted to…
From - Diagnostic Testing & Emerging Technologies
As of Oct. 1, new federal mandatory guidelines for workplace drug testing expanded to include the authority to test for…
From - Diagnostic Testing & Emerging Technologies
IDWeek, the combined annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, and…